/ / / 07.20.10 / / /
Ricerca Biosciences Releases Foresight Similarity Analysis Service
(Concord, OH; July 20, 2010) – Ricerca Biosciences, LLC, a uniquely integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, is pleased to announce its innovative similarity analysis service, Foresight™.
Foresight allows compound assay results to be compared against the assay results of a large reference set of pharmacologically active compounds. The tool helps predict in vivo effects from in vitro pharmacology data and provides insight into additional, non-obvious compound activities.
The analysis service allows scientists to discover clues to the possibilities of a compound, providing a resource for discovery and innovation. Foresight can be used to direct compound modification to avoid adverse effects and determine new indications for safe or novel compounds.
“Foresight provides a glimpse into the future of a compound and uses data from the past to suggest ways to increase the acuity of that vision. Additionally, Foresight allows our clients to apply their scientific know-how to years of historical data with sophisticated analysis tools. Until August 31, 2010, we are offering an introductory price of $3,500 per compound,” stated Chairman and CEO of Ricerca, Ian Lennox.
For over forty years, Ricerca has been working with clients to profile compounds in the discovery space. With the development of this tool, Ricerca can now offer interpretation and predictive analysis of pharmacological data.
Ricerca offers a unique spectrum of services for the areas of preclinical discovery and development for biopharmaceutical registration, agrochemical registration and environmental analysis.
About Ricerca Biosciences
Ricerca Biosciences, LLC, offers a comprehensive suite of discovery and preclinical services to support drug candidates from discovery through IND on a global scale. Capabilities in discovery include molecular through in vivo screening and profiling, medicinal chemistry, IND-enabling toxicology, API process chemistry and cGMP manufacturing and scale-up. At Ricerca, our scientific excellence and reliable, cost-effective strategies help accelerate your drug discovery programs via our U.S. based facilities in Concord, Ohio, and Bothell, Washington, and our ISO 9001-certified facilities in Taipei, Taiwan, and Lyon, France. The Lyon and Bothell facilities also hold AAALAC certification.